Host natural killer T cells induce an interleukin-4-dependent expansion of donor CD4+CD25+Foxp3+ T regulatory cells that protects against graft-versus-host disease.
about
Transplantation Tolerance Induction: Cell Therapies and Their MechanismsDonor hematopoiesis in mice following total lymphoid irradiation requires host T-regulatory cells for durable engraftment.Path to clinical transplantation tolerance and prevention of graft-versus-host disease.The changed balance of regulatory and naive T cells promotes tolerance after TLI and anti-T-cell antibody conditioning.Conditioning regimens for hematopoietic cell transplantation: one size does not fit allThe biology of graft-versus-host disease: experimental systems instructing clinical practice.The interaction between regulatory T cells and NKT cells in the liver: a CD1d bridge links innate and adaptive immunity.The role of natural killer T cells in costimulation blockade-based mixed chimerismRequirement for interactions of natural killer T cells and myeloid-derived suppressor cells for transplantation tolerance.A short pulse of IL-4 delivered by DCs electroporated with modified mRNA can both prevent and treat autoimmune diabetes in NOD mice.Influenza infection in suckling mice expands an NKT cell subset that protects against airway hyperreactivity.CD4+ invariant natural killer T cells protect from murine GVHD lethality through expansion of donor CD4+CD25+FoxP3+ regulatory T cells.A polymorphism in TIM1 is associated with susceptibility to severe hepatitis A virus infection in humansIntestinal helminths regulate lethal acute graft-versus-host disease and preserve the graft-versus-tumor effect in mice.Biomarkers in chronic graft-versus-host diseaseTotal lymphoid irradiation-antithymocyte globulin conditioning and allogeneic transplantation for patients with myelodysplastic syndromes and myeloproliferative neoplasms.Flagellin, a TLR5 agonist, reduces graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients while enhancing antiviral immunityInteractions between NKT cells and Tregs are required for tolerance to combined bone marrow and organ transplants.Donor bone marrow cells are essential for iNKT cell-mediated Foxp3+ Treg cell expansion in a murine model of transplantation tolerance.Atorvastatin for the Prophylaxis of Acute Graft-versus-Host Disease in Patients Undergoing HLA-Matched Related Donor Allogeneic Hematopoietic Stem Cell Transplantation (allo-HCT).Regulatory T Cell Immunotherapy in Immune-Mediated DiseasesFavorable preliminary results using TLI/ATG-based immunomodulatory conditioning for matched unrelated donor allogeneic hematopoietic stem cell transplantation in pediatric severe aplastic anemia.Cellular therapy following allogeneic stem-cell transplantation.Use of hematopoietic cell transplants to achieve tolerance in patients with solid organ transplantsRisks and benefits of sex-mismatched hematopoietic cell transplantation differ according to conditioning strategyIncidence and Pattern of Graft-versus-Host Disease in Patients Undergoing Allogeneic Transplantation after Nonmyeloablative Conditioning with Total Lymphoid Irradiation and Antithymocyte GlobulinRegulatory T cells and natural killer T cells for modulation of GVHD following allogeneic hematopoietic cell transplantation.TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors.Stable mixed chimerism and tolerance to human organ transplants.Targeting Treg cells in situ: emerging expansion strategies for (CD4(+)CD25(+)) regulatory T cells.Anti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.New perspectives on the biology of acute GVHD.Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease.NKT cells, Treg, and their interactions in bone marrow transplantation.Translational studies in hematopoietic cell transplantation: treatment of hematologic malignancies as a stepping stone to tolerance induction.Emerging concepts in haematopoietic cell transplantation.Regulatory immune cells in transplantation.O death where is thy sting? Immunologic tolerance to apoptotic self.Regulatory T cells in allogeneic stem cell transplantation.Invariant Natural Killer T Cells As Suppressors of Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation
P2860
Q26751022-C678DBE5-2F70-4D64-9FA6-FC936B44AC84Q33556957-B9CF1D30-12C8-4D19-B774-B2036D54AD1DQ33734003-F703F639-A14A-4E08-9A04-8D63A3CB761EQ33914718-2421F13C-CE81-4AD1-A7C5-7BB154642CEBQ33917170-B4A895DC-3B70-4046-8465-49BEAE166872Q33917175-3D89DB8E-AD17-4E60-9A76-E7B2BC65ECC5Q34071745-116A8962-050B-4FBC-9D6A-6FC332A65288Q34356212-A7811173-209F-4CD5-9BBE-CA03F60496AAQ34381246-6FDD2009-9A11-4A58-9A1C-DECD554046B4Q34382930-E1F17DF6-265A-4DA7-A5C9-5B019D637B55Q34429040-C0CFBD29-B276-47A6-B9B6-4548FE112A20Q34551230-AAFCA5D2-AF42-4CC2-B7FA-273A1CAA0E78Q34627078-7238C17E-1BF7-455F-A71E-21EFD3400D11Q34980164-80F8EA06-1F35-4F1D-9237-FFA8AB1E27CEQ35094374-88470189-9857-4C82-A93B-729E63F86B9CQ35317371-E0D4E62A-2666-4DCE-A1A7-E6ED68F25A63Q35691842-E3101FCA-98D9-44D7-9649-7C5D54A1F074Q35776458-41115B3A-0591-4D9A-9194-9423398B476AQ36262113-72D68D8E-0B8E-46E5-9455-97D4F6494889Q36445685-0413E5FC-A574-4B83-83C7-116312251399Q36462109-34C49BAA-0433-4C97-8B1C-8C19ECF4EDDCQ36514033-81CEA80E-F75B-46F4-BB83-8C36A20EB5FDQ36612643-EDAB4D84-2349-4CCB-B044-39EB38391B00Q36727857-C3D65771-6681-40DB-A8B0-827BB8F49CFEQ36779768-256247BE-F19F-4FC9-A52C-F00822C16BBDQ36838087-41D644F6-E512-4155-B614-5B42FAA29CE8Q37272005-1C6C4833-DE87-42BC-A541-B50C5A850088Q37291642-BD67DAB1-9D4D-4125-8ACB-FEB9197A45ABQ37337098-F6C69A0E-AA28-4249-BC4C-BB782B766396Q37595721-A5AF8216-2988-4046-9BB5-3A82C346E87FQ37618811-87614673-F3D4-4EE2-9F6F-C884345FA045Q37641063-AE4DF674-FAA7-4A3A-AD9C-A5BBA5F35119Q37737987-0D34AF45-9A58-4613-9E24-7B6FD775E815Q37768104-1A9DBD5D-10A3-43B5-9BE4-6B00F7AC0FC2Q37894465-3A463638-E71E-45A8-926A-E4340E5531F2Q38013047-6D1FE6A0-4744-4762-8803-E81CEEF51C21Q38013048-0A4AFC49-8E64-4B31-A8B4-1B09C977212CQ38078769-9D70E03C-2069-4F51-BEC5-3D96A4778529Q38112114-CDFF1E28-63B3-4E41-BA0D-44729FF6E3B8Q38616695-C4B67E11-4C5D-4F42-9AD4-D6CA1CD5CF8A
P2860
Host natural killer T cells induce an interleukin-4-dependent expansion of donor CD4+CD25+Foxp3+ T regulatory cells that protects against graft-versus-host disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Host natural killer T cells in ...... nst graft-versus-host disease.
@en
Host natural killer T cells in ...... nst graft-versus-host disease.
@nl
type
label
Host natural killer T cells in ...... nst graft-versus-host disease.
@en
Host natural killer T cells in ...... nst graft-versus-host disease.
@nl
prefLabel
Host natural killer T cells in ...... nst graft-versus-host disease.
@en
Host natural killer T cells in ...... nst graft-versus-host disease.
@nl
P2093
P2860
P1433
P1476
Host natural killer T cells in ...... nst graft-versus-host disease.
@en
P2093
Asha B Pillai
Samuel Strober
Suparna Dutt
Tracy I George
P2860
P304
P356
10.1182/BLOOD-2008-06-165506
P407
P577
2009-02-12T00:00:00Z